CMO Reality Check: Are You Still Running Campaigns Like It’s 2017?
Blog

CMO Reality Check: Are You Still Running Campaigns Like It’s 2017?

Honestly, pharma marketing hasn’t changed as much as we pretend it has. Yes, there are more webinars, more emailers, more digital banners. But look under the hood, and you’ll see the same slow planning cycles, manual approvals, disconnected teams, and field-force-led rollouts.

If you’re leading digital marketing in pharma right now, ask yourself this: Are you actually doing digital, or just dressing up traditional campaigns in new channels?

The truth? A lot of pharma is still stuck in 2017. And in a market as dynamic and competitive as India, that’s not just outdated, but also it’s dangerous.

You’re Not Competing With Other Pharma Brands. You’re Competing With Expectations.

Doctors today use Netflix, WhatsApp, Cred, and Amazon. Then they open your three-page PDF on their phone. See the problem?

Digital marketing in pharma can’t be judged against other pharma campaigns anymore. It’s judged against every other digital experience an HCP or patient interacts with daily. If your brand doesn’t feel intuitive, relevant, or easy to engage with, it gets ignored, no matter how good your science is.

The benchmark has shifted. And pharma needs to catch up, fast.

The Symptoms of a 2017 Marketing Setup

Here’s how you know if your marketing operation is stuck in the past:

  1. Campaigns take weeks to launch because MLR reviews are still done over email
  2. Sales and digital teams don’t work in the same system, or even on the same data
  3. All doctors get the same email blast, regardless of specialty, location, or engagement history
  4. You measure success by "reach" because attribution is too messy to trust
  5. Reps still carry static PDFs instead of interactive, tracked content

Sound familiar? Then you're not alone. Most pharma brands in India are still relying on muscle memory instead of modern marketing infrastructure. But here’s the real problem- it’s costing you growth.

Why Digital Marketing in Pharma Must Be Built, Not Bought

You can’t fix this with a new agency or a fancy CRM license. The brands getting it right are the ones treating digital marketing in pharma like a capability to be built, not a service to be outsourced.

That means building:

  1. A tech stack that connects CRM, MLR, campaign orchestration, and analytics
  2. An internal process that gets campaigns live in days, not months
  3. A data strategy that tells you who’s engaging, where, and why
  4. A mindset that treats marketing as a revenue engine, not just a brand wrapper

The point isn’t to go full D2C overnight. It’s to create a marketing operation that’s faster, smarter, and better aligned with how today’s doctors and patients actually behave.

UCPMP Isn’t a Constraint. It’s a Catalyst.

There's the elephant in the boardroom: UCPMP 2024. And you haven't yet addressed it! Every pharma leader is nervous about compliance. Many are using it as a reason to slow down. That’s a mistake.

The companies ahead of the curve are using UCPMP as a forcing function. To clean up their messaging. To audit their tools. To build MLR workflows that are fast, auditable, and legally bulletproof.

You don’t need to fear regulation. Rather, you need to be equipped for it. That’s where modern digital marketing in pharma makes the difference. It gives you structure without friction. Guardrails without red tape.

Personalization Is No Longer Optional

Doctors today expect relevance. A gastroenterologist in Mumbai doesn’t want the same campaign as a diabetologist in Coimbatore. Your content, cadence, and channel need to adapt based on who they are, what they prescribe, and how they’ve engaged in the past.

The problem? Most pharma companies in India don’t even have that level of doctor data in one place. Let alone the automation to act on it.

Real personalization means:

  1. Integrating rep data with digital behavior
  2. Building dynamic journeys, not one-off blasts
  3. Giving doctors control over how they want to be contacted

That’s the difference between being ignored and being remembered. And the brands that figure this out first will dominate HCP mindshare.

The Hidden Cost of Slow Campaigns

Every week you delay a launch, your competitor takes more shelf space in the doctor’s mind. Every time your approval workflow stalls, your reps lose momentum. Every time you can’t measure results, your next campaign is a shot in the dark.

Digital marketing in pharma isn’t just about visibility, but about velocity. And right now, speed is a competitive advantage very few brands have figured out.

This isn’t about rushing. It’s about designing systems that let your team move confidently, with built-in compliance and real-time feedback loops.

You Don’t Need a Transformation. You Need a System.

The word "digital transformation" has been beaten to death. You don’t need transformation. You need execution. A system that lets you launch compliant campaigns fast. That connects your teams. That personalizes at scale. That shows you what's working and what’s not.

This is what leading CMOs are quietly building: not just a digital team, but a digital core to their entire marketing function. The gap between pharma brands will no longer be in budgets; it’ll be in system design.

Final Word

If your marketing still runs like it did in 2017, you’re not falling behind; you’re already there. But the good news is, the gap is fixable. It starts with asking the hard questions, getting your systems in order, and building the capability to move at the speed modern pharma demands.

And if that resonates with where your team is stuck right now, maybe it’s time to look at what the right MarTech partner can help you build.

Download the Drupal Guide
Enter your email address to receive the guide.
get in touch